AIM ImmunoTech
35 hedge funds and large institutions have $1.67M invested in AIM ImmunoTech in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
3% more funds holding
Funds holding: 34 → 35 (+1)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
50% less capital invested
Capital invested by funds: $3.36M → $1.67M (-$1.69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$32.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$6.69K |
| 4 |
Renaissance Technologies
New York
|
+$5.58K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$224K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$12K |
| 3 |
LPL Financial
San Diego,
California
|
-$9K |
| 4 |
Millennium Management
New York
|
-$5.2K |
| 5 |
VF
Virtu Financial
New York
|
-$3.72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SC
26
Stephens Consulting
Flint,
Michigan
| $468 | – | – | – |
|
|
HI
27
Hoey Investments
Coatesville,
Pennsylvania
| $312 | – | – | – |
|
28
Wells Fargo
San Francisco,
California
| $227 | – | – | – |
|
|
CFGS
29
Concourse Financial Group Securities
Birmingham,
Alabama
| $155 | +$232 | +5 | New |
|
|
TWC
30
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $73 | – | – | – |
|
31
Osaic Holdings
Scottsdale,
Arizona
| $71 | -$93 | -2 | -8% |
|
32
Bank of America
Charlotte,
North Carolina
| $34 | +$46 | +1 | New |
|
|
HNB
33
Huntington National Bank
Columbus,
Ohio
| $18 | – | – | – |
|
|
NMG
34
New Millennium Group
Sandy,
Utah
| $10 | – | – | – |
|
|
CS
35
Credit Suisse
Zurich,
Switzerland
| $3 | – | – | – |
|
|
36
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | -$12K | -200 | Closed |
|
|
37
LPL Financial
San Diego,
California
| – | -$9K | -160 | Closed |
|
38
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$186 | -4 | Closed |
|
|
CCMI
39
Creative Capital Management Investments
San Diego,
California
| – | +$93 | +2 | New |
|
AIM Hedge Fund Activity: Q4 2022 in Review
35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q4 2022, worth a combined $1.67M — down 50% from $3.36M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AIM positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.7K. The largest seller was Morgan Stanley, cutting an estimated $224K.
- 35 institutional investors held AIM ImmunoTech (AIM) as of Q4 2022, up from 34 in Q3 2022.
- Funds reported $1.67M of AIM ImmunoTech stock for Q4 2022, down 50% quarter-over-quarter.
- 5 funds opened new AIM ImmunoTech positions in Q4 2022 and 3 closed out, a net change of +2 holders.
- The largest AIM ImmunoTech buyer in Q4 2022 was Citadel Advisors, an estimated $32.7K added.
- The largest AIM ImmunoTech seller in Q4 2022 was Morgan Stanley, an estimated $224K sold.
Based on aggregated 13F filings for Q4 2022.